Health Economics & Outcome Research

Health Economics & Outcome Research

Health Economics & Outcome Research

To bring real-world value to life sciences innovation, Health Economics & Outcomes Research (HEOR) plays a critical role. It bridges the gap between clinical trials and everyday patient care, helping stakeholders understand the true impact of new in complex, real-world settings.


At Polygon Health Analytics, we help you go beyond approval to demonstrate long-term value.

Why HEOR Matters in Today's Healthcare Landscape

HEOR is now a cornerstone for pharma, biotech, and healthcare organizations. It provides payers, providers, and patients with the evidence they need to make informed decisions about access, reimbursement, and clinical adoption.


While clinical trials answer "does it work?", HEOR answers

  • Is it worth it?
  • Does it improve quality of life compared to alternatives?
  • How does it perform in the real world?

How We Deliver Evidence That Drives Value

Our HEOR team combines academic rigor with real-world industry experience to deliver insights that are both credible and actionable. We don't just generate data - we shape compelling evidence packages that resonate with clinical, commercial, and payer audiences.

Real-World HEOR Services for Smarter Decision-Making

We tailor every engagement to support your specific objectives:

  • Outcomes-Driven Evidence Generation: Measure the impact of interventions across clinical, economic, and patient-centered outcomes.
  • Real-World Cost & Utilization Analysis: Understand treatment value through real-world cost, resource utilization, and budget impact studies.
  • Quality of Life & Patient-Reported Outcomes: Capture what matters most to patients - from symptom burden to treatment satisfaction - and reflect it in your value story.

Let's Advance Care With Smarter Evidence

Whether you're preparing for launch, informing pricing strategy, or navigating long-term market access, our HEOR team helps you build stakeholder confidence through real-world data and meaningful insights.

Our Insights on Data, Technology, and Healthcare

Drug Development Program Done Right: A Practical Checklist to Prevent Strategic Blind Spots
Drug Development Program Done Right: A Practical Checklist to Prevent Strategic Blind Spots
Nov 28, 2025
In the high-stakes world of pharmaceutical R&D, thousands of drug candidates are abandoned every year long before reaching patients. The harsh reality: fewer than...
Read more
QALYs Explained: The Metric That’s Shaping—and Dividing—Healthcare Policy
QALYs Explained: The Metric That’s Shaping—and Dividing—Healthcare Policy
Nov 10, 2025
Quality-Adjusted Life Years (QALYs) are a cornerstone concept in health economics. They measure the value of medical treatments by considering both how long people live and...
Read more
Value-Based Health Care: Shifting the Focus from Quantity to Quality
Value-Based Health Care: Shifting the Focus from Quantity to Quality
Oct 23, 2025
Understand how value-based health care shifts focus from volume to outcomes, rewarding better results, reducing costs and improving patient care....
Read more
View all